NNNS: Behavior Changes, Cognitive Function and Moods (2006)
- Electronic databases such as Medline, Chemical Abstracts, Science Citation Index, Biosis, Food Science and Technology Abstracts, Agricola, Toxline
- Articles identified from 1970s - 2002
- Published worldwide in peer reviewed journals, with the exception of a few abstracts and book chapters
- Search terms: aspartame, Nutrasweet, aspartic acid, phenylalanine, methanol, diketopiperazine
Recruitment
30+ years of research, over 700 research articles available on aspartame safety. 28 studies used in this section.
Design
Review article.
Blinding used (if applicable)
Some studies used blinding.
Intervention (if applicable)
Aspartame and phenylalanine intake.
Statistical Analysis
Not statistically analyzed.
Timing of Measurements
Testing generally completed before and after aspartame or phenylalanine consumption
Dependent Variables
- Behavior
- Cognitive Function
- Mood
- All assessed using various tests, specifics are listed under Results
Independent Variables
- Aspartame and/or phenylalanine intake at varying levels and varying time periods, specifics are listed under Results
Control Variables
Initial N: 28 studies, subjects per study ranging from 8 - 120 subjects
Attrition (final N): See above
Age: All age groups
Ethnicity: Not mentioned
Other relevant demographics:
Anthropometrics
Location: Worldwide
Other Findings
Studies on Healthy Humans (9 studies):
Intake of aspartame (ranging from 180 mg - 10,080 mg or 15 - 60 mg/kg body wt) or phenylalanine (ranging from 840 mg - 5,040 mg) for 1 day - 1 month resulted in significant increases of plasma phenylalanine concentrations and phenylalanine/large neutral amino acid ratio, but there were no effects on subjective feelings of hunger, mood or arousal, or behavioral tests such as auditory and visual reaction time tasks, Wilkinson auditory vigilance test, Digit Symbol Substitution Test, tapping test, Profile of Mood States, Visual Analogue Mood Scales, 16-item word list, Stanford Sleepiness Scale, EEGs, SPARTANS cognitive battery of aviation-related information processing tasks.
Studies with Adults Heterozygous for Phenylketonuria (PKUH) (4 studies):
Intake of aspartame ranging from 15 - 45 mg/kg body wt for 12 weeks had no effect on the Amsterdam Neuropsychological Tasks battery including tests for visual information processing and executive function of varying complexity.
Studies with Normal Children (4 studies):
Intake of aspartame ranging from 10 - 34 mg/kg body wt for 1 day - unspecified phase length had no effect on learning, behavior or mood as assessed by associative learning task, an arithmetic test, Children's Depression Inventory, the State Scale of the State-Trait Anxiety Inventory for Children, and several observational measures. Authors reported decreased minor and gross motor behavior, and increased inappropriate behaviors after sucrose consumption but not aspartame, as well as reduced crying in newborns with both aspartame and sucrose as newborns respond preferentially to sweetness.
Studies with ADD, ADHD or Sugar-Sensitive Children (6 studies):
Intake of aspartame at 34 mg/kg body wt for 1 day - 2 weeks had no effect on behavior, cognitive function, classroom behavior, noncompliance with adult requests, peer interactions, academic productivity and accuracy, learning or attention span, as assessed by Matching Familiar Figures Test, Children's Checking Task, Airplane Test, Wisconsin Card Sorting Test, Multigrade Inventory for Teachers, Conners Behavior Rating Scale, Subjects Treatment Emergent Symptom Scale.
Studies with Both Normal and Sensitive Children (5 studies):
Intake of aspartame at 32 +/- 8.9 mg/kg body wt - 38 +/- 13 mg/kg body wt for 1 day - 3 weeks had no effect on behavior, activity level, or fine or gross motor coordination, aggressive behaviors, or cognitive function.
Other: | No funding reported |
Quality Criteria Checklist: Review Articles
|
|||
Relevance Questions | |||
1. | Will the answer if true, have a direct bearing on the health of patients? | Yes | |
2. | Is the outcome or topic something that patients/clients/population groups would care about? | Yes | |
3. | Is the problem addressed in the review one that is relevant to dietetics practice? | Yes | |
4. | Will the information, if true, require a change in practice? | Yes | |
Validity Questions | |||
1. | Was the question for the review clearly focused and appropriate? | Yes | |
2. | Was the search strategy used to locate relevant studies comprehensive? Were the databases searched and the search termsused described? | Yes | |
3. | Were explicit methods used to select studies to include in the review? Were inclusion/exclusion criteria specified andappropriate? Wereselectionmethods unbiased? | Yes | |
4. | Was there an appraisal of the quality and validity of studies included in the review? Were appraisal methodsspecified,appropriate, andreproducible? | No | |
5. | Were specific treatments/interventions/exposures described? Were treatments similar enough to be combined? | ??? | |
6. | Was the outcome of interest clearly indicated? Were other potential harms and benefits considered? | Yes | |
7. | Were processes for data abstraction, synthesis, and analysis described? Were they applied consistently acrossstudies and groups? Was thereappropriate use of qualitative and/or quantitative synthesis? Was variation in findings among studies analyzed? Were heterogeneity issued considered? If data from studies were aggregated for meta-analysis, was the procedure described? | ??? | |
8. | Are the results clearly presented in narrative and/or quantitative terms? If summary statistics are used, are levels ofsignificance and/or confidence intervals included? | Yes | |
9. | Are conclusions supported by results with biases and limitations taken into consideration? Are limitations ofthe review identified anddiscussed? | No | |
10. | Was bias due to the review's funding or sponsorship unlikely? | Yes | |